Search results for "Screening test"

showing 10 items of 44 documents

Photoinduced chemiluminescence of pharmaceuticals

2005

Abstract A screening test for the forward development of chemiluminescence systems able to determine pharmaceutical compounds is reported. The test is based on the on-line photodegradation of the drugs by using a photoreactor consisting of 697 cm × 0.5 mm PTFE tubing helically coiled around an 8 W low-pressure mercury lamp. Photodegraded pharmaceuticals are detected by direct chemiluminescence of the resulting photofragments and their subsequent reaction with potassium permanganate in sulphuric acid medium as oxidant. The screening comprised 97 compounds with different molecular structures and relevant members of the most important families of pharmaceuticals are tested (amino acids, carbox…

LuminescenceLightScreening testPhotochemistryClinical BiochemistryPharmaceutical Sciencebeta-LactamsAnalytical Chemistrylaw.inventionStructure-Activity Relationshipchemistry.chemical_compoundAlkaloidsOxidants PhotochemicalPotassium PermanganatePhenothiazineslawDrug DiscoverymedicineOrganic chemistryEphedrinePhotodegradationSpectroscopyChemiluminescencechemistry.chemical_classificationBicyclic moleculePhotodissociationHydrogen-Ion ConcentrationAmino acidPotassium permanganatePharmaceutical Preparationschemistrymedicine.drugJournal of Pharmaceutical and Biomedical Analysis
researchProduct

Co-occurrence of developmental delays in a screening study of 4-year-old Finnish children

2004

The aim of this population study was to examine the severity and prevalence of co-occurring developmental delays in 4-year-old children, the rate of overlapping problems, and sex differences. A sample of 434 children (196 males, 238 females; mean age 4 years 3 months, SD 1 month) were administered the 'Lene' test: a comprehensive neurodevelopmental screening test. Results suggest that co-occurrence of attention-behavioural, motor-perceptual, and language delays occurring in school-aged children could already be detected at the age of 4 years. Isolated delays were usually mild, but co-occurring difficulties were mostly moderate or severe. Overlap between developmental delays depended on the …

MalePediatricsmedicine.medical_specialtyScreening testDevelopmental DisabilitiesComorbiditySpeech DisordersCohort StudiesCatchment Area HealthDevelopmental NeurosciencemedicineHumansMass ScreeningRisk factorChildFinlandScreening studyLanguage DisordersCo-occurrenceMean agemedicine.diseaseComorbidityMotor Skills DisordersChild PreschoolPediatrics Perinatology and Child HealthPopulation studyFemaleNeurology (clinical)Cognition DisordersFactor Analysis StatisticalPsychologyCohort studyDevelopmental Medicine & Child Neurology
researchProduct

Evaluation of the psychometric properties of “the Norwegian screening test for dyslexia”

2018

The aim of this study was to develop and investigate the psychometric properties of a screening protocol for Norwegian students in upper secondary school. The protocol was designed to assess skills that are at stake in dyslexia. It was administered to 232 students. In the absence of a “gold standard,” comparisons were made between students who reported normal literacy skills (n = 184) and literacy problems (n = 48). Significant group differences were found across all areas. Logistic regression and receiver operating characteristic curve analyses demonstrated good discriminatory power. The screening protocol met the standards for reliability and validity. It has the potential to be a useful …

MalePsychometricsiltalukiotheritabilityLogistic regressionNorjaspellingDevelopmental and Educational Psychologykeskiasteen koulutusReliability (statistics)ta515SchoolsNorway05 social sciences050301 educationGeneral MedicineperiytyvyyslanguageFemaleyläkouluPsychologyupper secondary050104 developmental & child psychologyClinical psychologyAdolescentPsychometricseducationExperimental and Cognitive PsychologyNorwegianbehavioral disciplines and activitiesEducationYoung AdultepäjärjestysdyslexiamedicineHumansdysleksia0501 psychology and cognitive sciencesStudentsUpper secondary general schools (evening classes)reading (activity)screening testProtocol (science)Receiver operating characteristicGold standardDyslexiaReproducibility of Resultslukeminen (toiminta)medicine.diseaselanguage.human_languageBehavior Rating Scalelukihäiriöt0503 educationDyslexia
researchProduct

Relationship Between Cognitive-Behavioral Impairment and Clinical and Functional Parameters in ALS and Reliability of the Edinburgh Cognitive and Beh…

2019

Background Although it is widely recognized that a high percentage of individuals with amyotrophic lateral sclerosis (ALS) have cognitive and behavioral impairment, the associated clinical and functional parameters remain unknown. ALS is typically assessed via screening tests, such as the Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Objective To investigate the relationship between cognitive-behavioral impairment and other clinical and functional parameters and to compare the assessment results from a set of standardized neuropsychological tests with those from the ECAS. Methods Forty individuals with ALS participated in the study. We assessed attention, memory and learning abilit…

Malemedicine.medical_specialtyScreening testCognitive NeuroscienceNeuropsychological TestsAudiology050105 experimental psychology03 medical and health sciences0302 clinical medicinemedicineHumansCognitive Dysfunction0501 psychology and cognitive sciencesTest selectionAmyotrophic lateral sclerosisSet (psychology)Reliability (statistics)business.industryAmyotrophic Lateral Sclerosis05 social sciencesNeuropsychologyCognitionGeneral MedicineMiddle Agedmedicine.diseasePsychiatry and Mental healthNeuropsychology and Physiological PsychologyFemaleCognition Disordersbusiness030217 neurology & neurosurgeryCognitive and Behavioral Neurology
researchProduct

Rotarod impairment: catalepsy-like screening test for antipsychotic side effects.

2009

Extrapyramidal motoric symptoms are casual side effects under antipsychotic medication. New generation antipsychotics are expected to have a reduced risk due to different receptor affinities. Here, haloperidol and the new generation antipsychotics, risperidone, amisulpride, and aripiprazole, were examined with both catalepsy test and rotarod performance test to screen for their usability in mice. Mice treated with haloperidol, risperidone, and aripiprazole showed dose and time-dependent impairment. Amisulpride-treated mice showed no signs of catalepsy. Catalepsy test and rotarod performance test were useful methods to detect side effects of both generation antipsychotics. Catalepsy test pro…

Malemedicine.medical_specialtyTime FactorsScreening testmedicine.medical_treatmentStatistics as TopicDrug Evaluation PreclinicalCatalepsyPharmacologyMotor ActivityRotarod performance testMiceBasal Ganglia DiseasesmedicineHaloperidolAnimalsAmisulprideAntipsychoticPsychiatryFreezing Reaction CatalepticRisperidoneDose-Response Relationship DrugGeneral NeuroscienceGeneral Medicinemedicine.diseaseDisease Models AnimalRotarod Performance TestAripiprazolePsychologymedicine.drugAntipsychotic AgentsThe International journal of neuroscience
researchProduct

Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease.

2016

Summary Objectives The treatment of inflammatory bowel disease (IBD) has been revolutionized by the use of immunomodulatory agents. Although these potent drugs are effective in controlling disease activity, they also cause an increased risk of new infections or reactivation of latent infections. On these premises, we aimed to provide guidance on the definitions of immunocompromised patients, opportunistic infections and the risk factors associated with their occurrence in an IBD context, and to suggest the proper screening tests for infectious diseases and the vaccination schedules to perform before and/or during therapy with immunomodulators. Methods All the most recent evidences – filtere…

Microbiology (medical)medicine.medical_specialtyBiologicSettore MED/17 - Malattie InfettiveScreening testOpportunistic InfectionDiseaseOpportunistic InfectionsInflammatory bowel diseaseImmunosuppressive Agent03 medical and health sciencesImmunocompromised Host0302 clinical medicinemedicineHumansIn patient030212 general & internal medicineIntensive care medicineImmunosuppressantCrohn's diseaseVaccinesUlcerative colitibusiness.industryInflammatory Bowel Diseasemedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisVaccinationCrohn's diseaseInfectious DiseasesInfectious disease (medical specialty)Immunology030211 gastroenterology & hepatologybusinessVaccineImmunosuppressive AgentsHumanThe Journal of infection
researchProduct

Endometrial and Cervical Cancers

2021

Uterine corpus and cervical cancers are showing, in the last decades, increasing incidence and mortality in industrialized and developing countries, respectively; on the other hand, innovative therapeutic strategies are emerging for the management of advanced gynecological malignancies. Risk factors and predisposing conditions are widely and continually studied; thus, prevention, through lifestyle correction and/or validated screening tests, could represent a promising tool to diagnose earlier and reduce mortality of uterine cancers. Herein, management of endometrial and cervical tumors from diagnosis to commonly applied standards of care and experimental frontiers are depicted so as to pro…

Oncologymedicine.medical_specialtyScreening testbusiness.industryIncidence (epidemiology)Endometriummedicine.diseasemedicine.anatomical_structureUterine corpusUterine cancerInternal medicinemedicinePersonalized medicinebusinessCervixChemoradiotherapy
researchProduct

Health Outcomes of Infants with Vitamin B12 Deficiency Identified by Newborn Screening and Early Treated

2021

Objective To evaluate the clinical outcomes at age 1.5 ± 0.5 years of infants with vitamin B12 deficiency identified by newborn screening (NBS). Study design Prospective multicenter observational study on health outcomes of 31 infants with vitamin B12 deficiency identified by NBS. Neurodevelopment was assessed by the Denver Developmental Screening Test. Results In 285 862 newborns screened between 2016 and 2019, the estimated birth prevalence of vitamin B12 deficiency was 26 in 100 000 newborns, with high seasonal variations (lowest in summer: 8 in 100 000). Infants participating in the outcome study (N = 31) were supplemented with vitamin B12 for a median (range) of 5.9 (1.1-16.2) months. …

Pediatricsmedicine.medical_specialtyNewborn screeningbusiness.industryDenver Developmental Screening TestPrenatal careHealth outcomes03 medical and health sciences0302 clinical medicine030225 pediatricsPediatrics Perinatology and Child HealthmedicineObservational study030212 general & internal medicineVitamin B12businessThe Journal of Pediatrics
researchProduct

Imaging the COVID-19: a practical guide

2021

The Coronavirus Disease 2019 (COVID-19) represents the first medical catastrophe of the new millennium. Although imaging is not a screening test for COVID-19, it plays a crucial role in evaluation and follow-up of COVID-19 patients. In this paper, we will review typical and atypical imaging findings of COVID-19.

Pulmonary and Respiratory Medicine2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Screening testbusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)lcsh:RCOVID-19lcsh:MedicineVirology030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineMedicineCOVID-19 pneumoniaCardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgeryCTCOVID-19; CT; COVID-19 pneumonia.
researchProduct

IgG1 antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency

2000

Background—In selective IgA deficiency (IgAD), there is no reliable screening test for coeliac disease (CD). Aim—To evaluate the usefulness of IgG1 antiendomysium and IgG antitissue transglutaminase tests for CD diagnosis in IgAD. Methods—IgA and IgG antigliadin antibodies (IgA- and IgG-AGA), IgA and IgG1 antiendomysium antibodies (IgA- and IgG1-EMA), and IgA and IgG antitissue

Screening testbiologyTissue transglutaminaseGastroenterologySelective IgA deficiencymedicine.diseaseEndomysiumCoeliac diseaseAntiendomysium antibodiesmedicine.anatomical_structureImmunopathologyImmunologymedicinebiology.proteinAntibodyGut
researchProduct